These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

927 related items for PubMed ID: 25804925

  • 1. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
    Liang J, Qi Z, Liu W, Wang P, Shi W, Dong W, Ji X, Luo Y, Liu KJ.
    Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925
    [Abstract] [Full Text] [Related]

  • 2. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
    Liu W, Hendren J, Qin XJ, Liu KJ.
    Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225
    [Abstract] [Full Text] [Related]

  • 3. Normobaric Hyperoxia Reduces Blood Occludin Fragments in Rats and Patients With Acute Ischemic Stroke.
    Shi S, Qi Z, Ma Q, Pan R, Timmins GS, Zhao Y, Shi W, Zhang Y, Ji X, Liu KJ.
    Stroke; 2017 Oct; 48(10):2848-2854. PubMed ID: 28931617
    [Abstract] [Full Text] [Related]

  • 4. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
    Ma Y, Li L, Kong L, Zhu Z, Zhang W, Song J, Chang J, Du G.
    Biomed Res Int; 2018 Oct; 2018():8943210. PubMed ID: 29850586
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Normobaric hyperoxia inhibits NADPH oxidase-mediated matrix metalloproteinase-9 induction in cerebral microvessels in experimental stroke.
    Liu W, Sood R, Chen Q, Sakoglu U, Hendren J, Cetin O, Miyake M, Liu KJ.
    J Neurochem; 2008 Dec; 107(5):1196-205. PubMed ID: 18786175
    [Abstract] [Full Text] [Related]

  • 7. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
    Zarisfi M, Allahtavakoli F, Hassanipour M, Khaksari M, Rezazadeh H, Allahtavakoli M, Taghavi MM.
    Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
    [Abstract] [Full Text] [Related]

  • 8. Oxygen therapy reduces secondary hemorrhage after thrombolysis in thromboembolic cerebral ischemia.
    Sun L, Zhou W, Mueller C, Sommer C, Heiland S, Bauer AT, Marti HH, Veltkamp R.
    J Cereb Blood Flow Metab; 2010 Sep; 30(9):1651-60. PubMed ID: 20424638
    [Abstract] [Full Text] [Related]

  • 9. Effects of tissue plasminogen activator on cerebral microvessels of rats during focal cerebral ischemia and reperfusion.
    Yang DY, Pan HC, Chen CJ, Cheng FC, Wang YC.
    Neurol Res; 2007 Apr; 29(3):274-82. PubMed ID: 17509227
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model.
    Allahtavakoli M, Amin F, Esmaeeli-Nadimi A, Shamsizadeh A, Kazemi-Arababadi M, Kennedy D.
    Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):335-9. PubMed ID: 25899606
    [Abstract] [Full Text] [Related]

  • 13. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y, Shimura H, Tanaka R, Yamashiro K, Koike M, Uchiyama Y, Urabe T, Hattori N.
    PLoS One; 2018 Nov; 13(5):e0198039. PubMed ID: 29795667
    [Abstract] [Full Text] [Related]

  • 14. Normobaric Hyperoxia Extends Neuro- and Vaso-Protection of N-Acetylcysteine in Transient Focal Ischemia.
    Liu Y, Liu WC, Sun Y, Shen X, Wang X, Shu H, Pan R, Liu CF, Liu W, Liu KJ, Jin X.
    Mol Neurobiol; 2017 Jul; 54(5):3418-3427. PubMed ID: 27177548
    [Abstract] [Full Text] [Related]

  • 15. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
    Pfefferkorn T, Rosenberg GA.
    Stroke; 2003 Aug; 34(8):2025-30. PubMed ID: 12855824
    [Abstract] [Full Text] [Related]

  • 16. Whole body hypothermia extends tissue plasminogen activator treatment window in the rat model of embolic stroke.
    Hassanipour M, Zarisfi M, Ehsani V, Allahtavakoli M.
    Life Sci; 2020 Sep 01; 256():117450. PubMed ID: 32087233
    [Abstract] [Full Text] [Related]

  • 17. Spatiotemporal evolution of blood brain barrier damage and tissue infarction within the first 3h after ischemia onset.
    Jin X, Liu J, Yang Y, Liu KJ, Yang Y, Liu W.
    Neurobiol Dis; 2012 Dec 01; 48(3):309-16. PubMed ID: 22813865
    [Abstract] [Full Text] [Related]

  • 18. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
    Zhang Y, Wang Y, Zuo Z, Wang Z, Roy J, Hou Q, Tong E, Hoffmann A, Sperberg E, Bredno J, Berr SS, Xie M, Lee K, Wintermark M.
    J Neurol Sci; 2014 Dec 15; 347(1-2):148-54. PubMed ID: 25292413
    [Abstract] [Full Text] [Related]

  • 19. Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis.
    Kelly MA, Shuaib A, Todd KG.
    Exp Neurol; 2006 Jul 15; 200(1):38-49. PubMed ID: 16624294
    [Abstract] [Full Text] [Related]

  • 20. Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke.
    Li M, Chen S, Shi X, Lyu C, Zhang Y, Tan M, Wang C, Zang N, Liu X, Hu Y, Shen J, Zhou L, Gu Y.
    J Neuroinflammation; 2018 Aug 23; 15(1):237. PubMed ID: 30139371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.